ONCOLYTICS BIOTECH INCONCOLYTICS BIOTECH INCONCOLYTICS BIOTECH INC

ONCOLYTICS BIOTECH INC

No trades
See on Supercharts

Price target

6.770.000.00%
The 7 analysts offering 1 year price forecasts for ONC have a max estimate of — and a min estimate of —.

Analyst rating

Based on 8 analysts giving stock ratings to ONC in the past 3 months.

EPS

‪0.00‬
Reported
Estimate
Reported
Estimate
Surprise

Revenue

‪0.00‬
Reported
Estimate
Reported
Estimate
Surprise
Be warned

Frequently Asked Questions


ONC EPS for the last quarter is −0.10 CAD despite the estimation of −0.10 CAD. In the next quarter EPS is expected to reach −0.10 CAD. Track more of ONCOLYTICS BIOTECH INC financials and stay on top of what is up with the company.
In the next quarter ONCOLYTICS BIOTECH INC revenue is expected to reach 0.00 CAD. Check out ONCOLYTICS BIOTECH INC revenue and earnings and make informed decisions.
According to analysts, ONC price target is 6.77 CAD with a max estimate of 9.00 CAD and a min estimate of 3.50 CAD. Check if this forecast comes true in a year, meanwhile watch ONCOLYTICS BIOTECH INC stock price chart and keep track of the current situation with ONC news and stock market news.
We've gathered opinions of 8 analysts rating ONC stock in the past 3 months. Most of them backed up the strong buy trend, and after taking into account other opinions, the overall rating was calculated as strong buy. Note that it's not a trading advice — your own analysis is still required.